Skip to main content
Top
Published in: Journal of Radiation Oncology 1/2018

01-03-2018 | Original Research

Assessment of contouring resource use and awareness of contouring guidelines among radiation oncologists

Published in: Journal of Radiation Oncology | Issue 1/2018

Login to get access

Abstract

Objective

Clinical questions arise frequently at the point of care, and approximately half of these questions go unanswered, representing an opportunity to improve quality of care. Radiation oncologists perform the unique task of contour delineation, which has been linked to decreased survival and increased toxicity when performed inaccurately. Little is known about how radiation oncologists approach contouring-related questions in clinical practice.

Methods

A survey was distributed to all attendees of an educational contouring symposium at the 2017 Annual Meeting of the American College of Radiation Oncology. Providers indicated their years of clinical experience and level of specialization and answered questions regarding resources used to answer contouring-related questions, awareness of consensus contouring guidelines, and barriers to guideline usage.

Results

Eighty-three out of 85 radiation oncologists attending the symposium returned the survey (97.6%). The majority of respondents were generalists (85%) and had over 10 years of clinical experience (73%). The most frequently used contouring resource was Radiation Therapy Oncology Group atlases (mean Likert score 4.1). Participants correctly identified the existence of consensus contouring guideline publications 42% of the time. The main barriers to guideline usage were a lack of awareness regarding publication (60%), poor ease of use (30%), lack of time (23%), and lack of comprehensiveness of available resources (21%).

Conclusion

This study provides information to guide further development and implementation of contouring resources, with radiation oncologists preferring resources that are atlas-based and can be accessed quickly and easily. Both self-reported and objectively tested awareness of consensus contouring guidelines was low, reflecting a need for better guideline dissemination.
Appendix
Available only for authorised users
Literature
15.
go back to reference Dillmon M, Goldberg JM, Ramalingam SS et al (2012) Clinical practice guidelines for cancer care: utilization and expectations of the practicing oncologist. J Oncol Pract 8(6):350–353 352 p following 353CrossRef Dillmon M, Goldberg JM, Ramalingam SS et al (2012) Clinical practice guidelines for cancer care: utilization and expectations of the practicing oncologist. J Oncol Pract 8(6):350–353 352 p following 353CrossRef
17.
18.
go back to reference Fuller CD, Nijkamp J, Duppen JC, Rasch CR, Thomas CR Jr, Wang SJ, Okunieff P, Jones WE 3rd, Baseman D, Patel S, Demandante CG, Harris AM, Smith BD, Katz AW, McGann C, Harper JL, Chang DT, Smalley S, Marshall DT, Goodman KA, Papanikolaou N, Kachnic LA, Radiation Oncology Committee of the Southwest Oncology Group (2011) Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting. Int J Radiat Oncol Biol Phys 79(2):481–489. https://doi.org/10.1016/j.ijrobp.2009.11.012 CrossRefPubMed Fuller CD, Nijkamp J, Duppen JC, Rasch CR, Thomas CR Jr, Wang SJ, Okunieff P, Jones WE 3rd, Baseman D, Patel S, Demandante CG, Harris AM, Smith BD, Katz AW, McGann C, Harper JL, Chang DT, Smalley S, Marshall DT, Goodman KA, Papanikolaou N, Kachnic LA, Radiation Oncology Committee of the Southwest Oncology Group (2011) Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting. Int J Radiat Oncol Biol Phys 79(2):481–489. https://​doi.​org/​10.​1016/​j.​ijrobp.​2009.​11.​012 CrossRefPubMed
19.
go back to reference Mavroidis P, Giantsoudis D, Awan MJ, Nijkamp J, Rasch CR, Duppen JC, Thomas CR Jr, Okunieff P, Jones WE 3rd, Kachnic LA, Papanikolaou N, Fuller CD, Southwest Oncology Group Radiation Oncology Committee (2014) Consequences of anorectal cancer atlas implementation in the cooperative group setting: radiobiologic analysis of a prospective randomized in silico target delineation study. Radiother Oncol 112(3):418–424. https://doi.org/10.1016/j.radonc.2014.05.011 CrossRefPubMedPubMedCentral Mavroidis P, Giantsoudis D, Awan MJ, Nijkamp J, Rasch CR, Duppen JC, Thomas CR Jr, Okunieff P, Jones WE 3rd, Kachnic LA, Papanikolaou N, Fuller CD, Southwest Oncology Group Radiation Oncology Committee (2014) Consequences of anorectal cancer atlas implementation in the cooperative group setting: radiobiologic analysis of a prospective randomized in silico target delineation study. Radiother Oncol 112(3):418–424. https://​doi.​org/​10.​1016/​j.​radonc.​2014.​05.​011 CrossRefPubMedPubMedCentral
20.
go back to reference Skinner A (2007) Survey research: designing an instrument. Johns Hopkins Bloomberg School of Public Health, Baltimore Skinner A (2007) Survey research: designing an instrument. Johns Hopkins Bloomberg School of Public Health, Baltimore
21.
go back to reference AJ W, Bosch WR, Chang DT et al (2015) Expert consensus contouring guidelines for intensity modulated radiation therapy in esophageal and gastroesophageal junction cancer. Int J Radiat Oncol Biol Phys 92(4):911–920CrossRef AJ W, Bosch WR, Chang DT et al (2015) Expert consensus contouring guidelines for intensity modulated radiation therapy in esophageal and gastroesophageal junction cancer. Int J Radiat Oncol Biol Phys 92(4):911–920CrossRef
22.
25.
go back to reference Cox BW, Spratt DE, Lovelock M, Bilsky MH, Lis E, Ryu S, Sheehan J, Gerszten PC, Chang E, Gibbs I, Soltys S, Sahgal A, Deasy J, Flickinger J, Quader M, Mindea S, Yamada Y (2012) International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 83(5):e597–e605. https://doi.org/10.1016/j.ijrobp.2012.03.009 CrossRefPubMed Cox BW, Spratt DE, Lovelock M, Bilsky MH, Lis E, Ryu S, Sheehan J, Gerszten PC, Chang E, Gibbs I, Soltys S, Sahgal A, Deasy J, Flickinger J, Quader M, Mindea S, Yamada Y (2012) International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 83(5):e597–e605. https://​doi.​org/​10.​1016/​j.​ijrobp.​2012.​03.​009 CrossRefPubMed
26.
30.
31.
go back to reference Grimshaw JM, Thomas RE, MacLennan G et al (2004) Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 8(6):iii–iiv 1-72CrossRef Grimshaw JM, Thomas RE, MacLennan G et al (2004) Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 8(6):iii–iiv 1-72CrossRef
37.
go back to reference Gillespie EF, Panjwani N, Golden DW, Gunther JR, Chapman TR, Brower JV, Kosztyla R, Bykowski JM, Sanghvi P, Murphy JD (2016) Multi-institutional randomized trial testing the utility of an interactive three-dimensional contouring atlas among radiation oncology residents. Int J Radiat Oncol Biol Phys 96(2):E416–E417. https://doi.org/10.1016/j.ijrobp.2016.06.1677 CrossRef Gillespie EF, Panjwani N, Golden DW, Gunther JR, Chapman TR, Brower JV, Kosztyla R, Bykowski JM, Sanghvi P, Murphy JD (2016) Multi-institutional randomized trial testing the utility of an interactive three-dimensional contouring atlas among radiation oncology residents. Int J Radiat Oncol Biol Phys 96(2):E416–E417. https://​doi.​org/​10.​1016/​j.​ijrobp.​2016.​06.​1677 CrossRef
Metadata
Title
Assessment of contouring resource use and awareness of contouring guidelines among radiation oncologists
Publication date
01-03-2018
Published in
Journal of Radiation Oncology / Issue 1/2018
Print ISSN: 1948-7894
Electronic ISSN: 1948-7908
DOI
https://doi.org/10.1007/s13566-018-0343-x

Other articles of this Issue 1/2018

Journal of Radiation Oncology 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine